InflaRx (IFRX) Total Current Liabilities (2022 - 2025)

InflaRx (IFRX) has disclosed Total Current Liabilities for 4 consecutive years, with $15.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities changed 0.18% to $15.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.1 million through Dec 2025, changed 0.18% year-over-year, with the annual reading at $15.1 million for FY2025, 0.18% changed from the prior year.
  • Total Current Liabilities hit $15.1 million in Q4 2025 for InflaRx, roughly flat from $15.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $18.1 million in Q4 2023 to a low of $13.3 million in Q4 2022.
  • Historically, Total Current Liabilities has averaged $15.4 million across 4 years, with a median of $15.1 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: soared 36.37% in 2023 and later decreased 16.47% in 2024.
  • Year by year, Total Current Liabilities stood at $13.3 million in 2022, then skyrocketed by 36.37% to $18.1 million in 2023, then fell by 16.47% to $15.1 million in 2024, then decreased by 0.18% to $15.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for IFRX at $15.1 million in Q4 2025, $15.1 million in Q4 2024, and $18.1 million in Q4 2023.